Monrovia- The National AIDS Commission (NAC) has raised alarm over a worrying rise in HIV infections in Liberia.  Tumu-jaheim ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with substance-use disorder in Vermont, Massachusetts and Rhode Island are impacted by ...

The Maldives has become the first country in the world to attain triple elimination of mother-to-child transmission of ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

The Standard Group Plc is a multi-media organization with investments in media platforms spanning newspaper print ...

From medical neglect to suicide, the lack of information on jail deaths can allow the same deadly problems to lead to more ...

BIC is an integrase strand transfer inhibitor that has a higher barrier to resistance and is only used in combination. LEN has been approved as a method of pre-exposure prophylaxis but has also been ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

Rohit Loomba, M.D., will hold the new endowed chair that was established in honor of the late biotech leader John C. Martin to further liver disease research ...